جست‌وجوی استاد و پژوهشگر

• Health
• Biomedicine
• Molecular Immunology
• +۳ مورد دیگر

Pärt Peterson (b. 1966) is a full-time Professor of Molecular Immunology at the University of Tartu, Faculty of Medicine . He has held various leadership roles including Head of the Institute of Biomedicine and Translational Medicine (2013–2015, 2019–2021) and currently serves on the Editorial Board of Immunology Letters and as a member of the Estonian Bioethics Council. Doctorate in Molecular Immunology (University of Tampere, 1996) Master's Degree in Biology (University of Tartu, 1992) His research focuses on central immune tolerance , autoimmune diseases , and genetic/epigenetic mechanisms in conditions like APECED syndrome. Recent work includes: Single-cell immunology of aging and autoimmune disorders Interferon autoantibodies in severe COVID-19 Macrophage reprogramming in cancer immunotherapy Epigenetic regulation of T-cell enhancer landscapes Publications from 2017–2024 demonstrate expertise in immunosenescence , viral immunology , and translational immunotherapy . He received Estonia's National Science Award in 2009 and 2022 for groundbreaking work on immune tolerance and aging immunity. Notable contributions include developing peptide-drug conjugates for tumor macrophage depletion and characterizing AIRE-dependent immune mechanisms . He actively participates in governmental science advisory bodies, including the COVID Science Council (2022–present).

Attila Becskeiمشاهده پروفایل

استاد

• Genetic Regulatory Circuits
• Cell Differentiation
• RNA Turnover
• +۴ مورد دیگر

Prof. Attila Becskei is a Professor at the Biozentrum, University of Basel, Switzerland, where he leads a research group focused on understanding genetic regulatory circuits and cell differentiation mechanisms. His work combines experimental approaches with mathematical modeling to investigate gene networks in yeast and mammalian cells. His educational background includes studies at the University of Szeged, Hungary (1992-1998), followed by postdoctoral work at EMBL, Heidelberg (1998-2002) and MIT, Cambridge (2002-2005). He served as an Assistant Professor at the University of Zurich (2006-2011) before becoming a Professor at the University of Basel in 2011. Prof. Becskei's research focuses on the principles of genetic regulatory circuits, with particular emphasis on feedback mechanisms, epigenetic processes, and RNA turnover regulation. His work explores how these elements control cellular adaptation strategies, decision-making processes, and differentiation. A significant portion of his research investigates stochastic and epigenetic processes in gene expression, particularly how long-range chromosomal interactions determine gene expression patterns. His laboratory has developed innovative methods such as the multiplexed gene control (MGC) technique to measure rapid mRNA turnover rates in yeast. His recent publications demonstrate a consistent focus on RNA dynamics, gene network regulation, and cellular differentiation mechanisms. The articles reveal a progression from fundamental studies of gene networks and bistability toward more specific applications in cancer biology and neuronal differentiation. A recurring theme across his work is the integration of mathematical modeling with experimental validation to understand complex biological systems. 2003 Human Frontiers Fellow 2005 Nobel prize winners conference award Prof. Becskei advises several doctoral students and postdoctoral researchers, including Samuel Mondal, Nicole Schiffelholz, and Dr. Sayanur Rahaman. His research group at the Biozentrum includes both experimental and computational scientists working collaboratively to advance understanding of genetic regulatory networks. The group has secured funding for multiple projects investigating mRNA turnover, cellular memory mechanisms, and stochastic gene expression processes. The Becskei laboratory at the University of Basel's Biozentrum maintains a multidisciplinary research environment where molecular biology techniques are combined with mathematical modeling approaches to investigate genetic regulatory circuits. The lab has made significant contributions to understanding how feedback regulation improves adaptation mechanisms and cellular memory.

• Autism
• Induced pluripotent stem cells
• Neuroscience
• +۴ مورد دیگر

Samuele Marro is an Assistant Professor in the Nash Family Department of Neuroscience and the Black Family Stem Cell Institute at the Icahn School of Medicine at Mount Sinai. His research program focuses on synaptic plasticity and its dysfunction in Fragile X syndrome, which represents the number one genetic cause of autism. Dr. Marro received his PhD in Human Biology from the Molecular Biotechnology Center at the University of Torino in Italy. He completed his postdoctoral training in pluripotent stem cell biology in the laboratory of Marius Wernig, MD PhD, at the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University. His laboratory utilizes human neurons directly differentiated from pluripotent stem cells and genetically modified using CRISPR/Cas9 tools to investigate neurodevelopmental disorders. His research spans multiple disciplines including neuroscience, stem cell biology, and genetic engineering, with particular emphasis on autism spectrum disorders and synaptic function. Dr. Marro's team has developed sophisticated protocols for generating precise disease models and investigating cellular mechanisms underlying neurological conditions. Analysis of Dr. Marro's 15 most recent publications reveals a consistent trajectory from foundational stem cell techniques to complex disease modeling. His work demonstrates expertise in CRISPR-based gene editing, single-cell analysis, and advanced imaging techniques applied to neurodevelopmental and neurodegenerative conditions. There is a clear progression toward increasingly sophisticated models of neurological disorders with translational applications. Dr. Marro serves as co-Director of the Stem Cell Engineering Core, which provides critical infrastructure services including derivation of iPSCs from patient blood samples, differentiation into specific cell types, and gene-editing to create or repair disease mutations for the Icahn School of Medicine community. This role positions him at the intersection of basic research and translational applications across multiple disciplines.

• Biomedical Informatics
• Cancer
• Cancer Genetics
• +۱۲ مورد دیگر

Robert Sebra, PhD, is a Professor in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai. He also serves as Director of The Center for Advanced Genomics Technology and Director of Technology Development for the Genomics Core Facility. Dr. Sebra is a faculty member of the Icahn Genomics Institute, where his research focuses on developing and applying advanced genomic technologies to understand disease mechanisms and improve translational outcomes across multiple disease areas. Dr. Sebra's research spans a wide range of genomic applications, with particular emphasis on cancer genetics, infectious disease, and molecular biology. His laboratory specializes in creating and applying bulk and single-cell molecular methods to generate highly resolved genomic data for variant discovery and annotation. His work integrates single-molecular and cellular genomics data with assays to assess chromatin accessibility, proteomics, and epigenetics to decipher factors of pathogenesis versus normal cellular functions. Key research areas include developing novel molecular methods, advancing high-throughput functional genomics, characterizing whole genomes for disease associations, analyzing pathogen transmission, and translating genomic data in oncologic diseases including gynecologic and breast cancers. Analysis of Dr. Sebra's recent publications reveals a strong focus on cutting-edge genomic technologies and their application across diverse disease areas. His work prominently features long-read sequencing approaches, single-cell multi-omics, and spatial transcriptomics to investigate cancer heterogeneity, HIV reservoir characterization, and neurological disorders. A recurring theme is the development and application of novel genomic methodologies to address previously intractable biological questions, particularly in the areas of tumor microenvironment analysis, viral persistence mechanisms, and cellular heterogeneity in complex tissues. Dr. Sebra has established significant leadership roles within Mount Sinai's genomic research infrastructure, directing both The Center for Advanced Genomics Technology and the Technology Development arm of the Genomics Core Facility. His work bridges basic genomic technology development with clinical translation, particularly in cancer and infectious disease applications. As evidenced by his extensive publication record, Dr. Sebra collaborates widely across disciplines, contributing genomic expertise to studies ranging from HIV persistence to disc degeneration to cancer immunotherapy. His industry relationship with Panacent Bio, where he serves as Founder/Co-Founder/Partner, further demonstrates his commitment to translating genomic discoveries into practical applications.

Jan Wilhelm Kornfeldمشاهده پروفایل

استاد

• Epigenetics
• Metabolism
• Non-coding RNA
• +۳ مورد دیگر

Jan Wilhelm Kornfeld is a Professor at the Department of Biochemistry and Molecular Biology, University of Southern Denmark, leading a research group focused on epigenetic regulation of energy metabolism in cardiometabolic diseases. After obtaining his PhD in Cell Biology from the Boltzmann Institute for Cancer Research (2008), he conducted postdoctoral research with Jens Brüning in Germany (2013), where he pioneered studies on obesity-associated microRNAs and hepatic insulin resistance. His independent research at CECAD (2013) and Max Planck Institute for Metabolism Research (2014) has been supported by prestigious grants including the Emmy-Noether Grant (2014) and ERC Starting Grant (2015). Education: PhD in Cell Biology, Boltzmann Institute for Cancer Research, Austria (2008) Postdoctoral Training, Jens Brüning Lab, Germany (2013) The Kornfeld Lab investigates epigenetic regulatory processes such as non-coding microRNAs (miRNA) and chromatin modifications that impact organismal, tissue, and cellular energy balance. Their research integrates molecular genomics , transgenic animal models , and inter-organ crosstalk to uncover disease-associated molecular signatures in obesity and type 2 diabetes (T2D). Key projects include miRNA perturbation in vivo, nutritional intervention strategies, and development of adeno-associated virus (AAV) gene therapy tools . Recent publications highlight work on dietary sulfur amino acid restriction , mitochondrial dysfunction in brown adipocytes, and miR-let-7 in intergenerational metabolic decline. His research spans transcriptional regulation , metabolomics , and non-coding RNA mechanisms in metabolic diseases. Scientific Awards: Emmy-Noether Grant (2014) ERC Starting Grant (2015) The lab actively trains Bachelor, Master, and ISA students in hypothesis-driven research, focusing on RNA-mediated gene regulation , chromatin dynamics , and (patho)physiological analysis . Collaborations with global experts and industrial partners enhance translational impact.

Ronghu Wuمشاهده پروفایل

استاد

• Mass spectrometry-based proteomics
• Protein post-translational modifications
• Glycoproteomics
• +۴ مورد دیگر

Ronghu Wu is a Professor in the School of Chemistry and Biochemistry at the Georgia Institute of Technology , where he leads the Wu Lab focused on cutting-edge mass spectrometry-based proteomics. His research integrates analytical chemistry, chemical biology, and biomedical sciences to understand protein post-translational modifications (PTMs), cell signaling, and cancer metabolism. Education M.S. and Ph.D. in Analytical Chemistry, University of Science and Technology of China Postdoctoral Fellow, Harvard Medical School (2009–2012) Research Interests Professor Wu’s group develops and applies novel liquid chromatography–mass spectrometry (LC-MS) strategies to investigate protein PTMs—especially glycosylation—protein dynamics, and their roles in disease. A major focus is on quantitative glycoproteomics to map the cell-surface glycoproteome (surfaceome) and to elucidate how aberrant glycosylation drives cancer metastasis and metabolic reprogramming. Complementary projects explore how protein modifications regulate cell signaling, stress responses, and therapeutic drug effects, with the ultimate goal of identifying new biomarkers and drug targets for personalized medicine. Scientific Awards ASMS Research Award (2016) NSF CAREER Award (2015) Blanchard Assistant Professorship (2014) Alexander von Humboldt Research Fellowship (2002–2004) Grants & Funding His research has been continuously supported by the U.S. National Science Foundation (NSF CAREER) and other competitive grants, enabling the development of innovative chemoproteomic tools and their application to clinically relevant problems. Laboratory & Team Professor Wu directs the Wu Lab located in the Engineering Biosystems Building (EBB 4011) at Georgia Tech. The multidisciplinary team comprises graduate students, postdoctoral researchers, and collaborators across chemistry, biology, and biomedical engineering departments.

Justin Kumarمشاهده پروفایل

استاد

• Developmental Biology
• Genetics
• Molecular Biology
• +۳ مورد دیگر

Justin Kumar is a Professor in the Department of Biology at Indiana University Bloomington, College of Arts & Sciences. His research focuses on molecular mechanisms of tissue fate specification, growth, and pattern formation using Drosophila eye development as a model system. His educational background includes: Ph.D. from Purdue University (1996) Postdoctoral Fellow at University of Southern California (1996-1997) Postdoctoral Fellow at Emory University (1998-2002) Dr. Kumar's work centers on the retinal determination (RD) network, a conserved set of transcription factors including Pax6 that act as master regulators of eye development. His lab investigates how this network prevents non-ocular fates (e.g., antennal or head epidermis), controls cell proliferation, and interacts with epigenetic complexes like Polycomb and Trithorax. Key research areas span developmental biology, chromatin regulation, and Drosophila genetics. Recent publications (2015-2018) reveal critical interactions between Pax6 and epigenetic machinery in eye development, demonstrating how disruptions cause homeotic transformations and how gene regulatory networks allocate organ fates. His work bridges developmental genetics and epigenetics with implications for congenital disorders. Notable awards include: Fellow of the American Association for the Advancement of Science (2019) IU Trustees Teaching Award (2015) IU Summer Faculty Fellowship (2006-2010) Dr. Kumar secures significant funding including an NIH R01 grant (EY014863) on repression of non-ocular fates and an IU CTSI pilot grant for transcriptome analysis. His lab leverages IU resources like the Bloomington Drosophila Stock Center and imaging facilities while mentoring graduate students in developmental genetics. He leads the FlyEyeLab in Myers Hall, utilizing IU's Drosophila Genome Resource Center, Flybase, and microscopy facilities. His team collaborates extensively with colleagues in developmental biology, gene regulation, and epigenetics across the university.

Huai Dengمشاهده پروفایل

دانشیار

• Molecular Biology
• Developmental Biology
• Genetics
• +۳ مورد دیگر

Huai Deng is an Associate Professor in the Department of Biology at the Swenson College of Science and Engineering, University of Minnesota Duluth, where he investigates molecular mechanisms of developmental adaptations to environmental stressors using Drosophila as a model system. His research centers on the Keap1-Nrf2 oxidative/xenobiotic response pathway and its roles beyond detoxification. His educational background includes: Postdoc at University of Michigan, HHMI Ph.D. at Iowa State University M.S. at Chinese Academy of Sciences B.S. at Wuhan University Dr. Deng's work spans Molecular and Developmental Biology , Epigenetics , and Advanced Imaging , with three core research thrusts: (1) developmental functions of dKeap1-CncC in metamorphosis and oogenesis; (2) epigenetic regulation of chromatin architecture; and (3) development of BiFC-based imaging tools for visualizing protein complexes on polytene chromosomes. His lab integrates Drosophila genetics, molecular biology, and live imaging to uncover how environmental toxins influence development through chromatin remodeling. Analysis of his publication record reveals consistent innovation in adapting fluorescence techniques to study transcription factor-chromatin interactions, with recent work emphasizing the pathway's developmental roles and nuclear architecture functions. His 2022-2024 publications demonstrate expanding focus on structural impacts of Keap1 in the nucleus. No scientific awards were documented in the source materials. Dr. Deng advises graduate students including MS candidate Emma Neidviecky in Integrated Biosciences, and actively recruits postdocs and undergraduates for projects on xenobiotic response mechanisms. His lab maintains strong technical development focus, particularly in chromatin imaging methodologies. The Deng Lab operates within UMD's Department of Biology, utilizing Drosophila polytene chromosome models and advanced microscopy to investigate how environmental stressors reprogram development through epigenetic mechanisms, with ongoing studies examining Keap1's interactions with nuclear lamina and chromatin modifiers.

• Neuroscience
• Epigenetics
• Cell Reprogramming
• +۴ مورد دیگر

Cheen Euong Ang is a Visiting Professor in the Department of Chemistry and Chemical Biology at Harvard University's Faculty of Arts and Sciences. Affiliated with the Zhuang Research Group, his work focuses on neuronal engineering, epigenetic regulation, and cellular reprogramming mechanisms. Department of Chemistry and Chemical Biology, Harvard University Zhuang Research Group, Faculty of Arts and Sciences His research spans neuroscience and epigenetics, with particular emphasis on: Direct neuronal reprogramming from somatic cells Epigenetic dynamics during cellular transitions Long non-coding RNA functions in brain development Matrix stiffness effects on chromatin states Neurodevelopmental disorder modeling Recent publications demonstrate expertise in: Neuronal differentiation using transcription factors Single-cell epigenomic profiling Transdifferentiation of immune cells to neurons Neurogenetic mechanisms in 22q11.2 deletion syndrome lncRNA-mediated pathogenic pathways

• Medical Biochemistry
• Molecular Biology
• Cellular Signaling
• +۳ مورد دیگر

J. Nathan Davis is a Professor of Medical Sciences at the Frank H Netter School of Medicine, Quinnipiac University, where he has served as faculty since 2013 and was one of the founding faculty members of the medical school. His primary teaching responsibilities focus on the basic science curriculum for the first two years of medical education, with specialized expertise in Medical Biochemistry and Molecular Biology. His educational background includes: BS from the University of Arkansas at Little Rock PhD from the University of Texas - Austin Dr. Davis' research centers on molecular mechanisms of cancer, particularly alterations in cellular signaling pathways and transcriptional regulation. His work extensively investigates the RUNX family of transcription factors in carcinomas, sphingolipid metabolism in cancer cells, and molecular pathways in prostate, ovarian, pancreatic, and brain cancers. Key methodologies include biochemical analysis of transcription factors, kinase signaling, and tumor suppressor mechanisms. Analysis of his publication record reveals a consistent trajectory from fundamental biochemical studies of lipid kinases and transcription factors (1990s-2000s) toward applied cancer biology (2010s), with recent expansion into medical education as evidenced by his 2023 pediatrics clerkship study. The predominant research themes span oncology, molecular signaling, and transcriptional regulation across diverse cancer models. No specific scientific awards are documented in the available information. While student advising details are not provided, Dr. Davis has maintained a significant research collaboration with Dr. Shari Meyers focusing on RUNX transcription factors in carcinomas. Grant funding specifics are not mentioned in the source material. His laboratory research has centered on collaborative investigations of transcription factor networks in cancer progression, particularly examining how RUNX proteins interact with signaling pathways to drive malignant phenotypes in epithelial cancers.

• Wnt/ß-catenin signaling
• Colorectal cancer
• Inflammatory bowel disease
• +۶ مورد دیگر

Dr. Gregory Yochum is an Associate Professor at Penn State University, holding dual appointments in the Department of Molecular and Precision Medicine and the Department of Surgery at Penn State College of Medicine. He is affiliated with the Penn State Cancer Institute as a Mechanisms of Carcinogenesis researcher. PhD in Molecular Biology (University of Utah, 1996-2002) Postdoctoral Fellowship at Vollum Institute for Advanced Biomedical Research (2002-2009) Dr. Yochum's research focuses on Wnt/ß-catenin signaling in intestinal biology, with applications to colorectal cancer (CRC) , inflammatory bowel disease (IBD) , and epithelial barrier function . His lab investigates how TCF/ß-catenin complexes regulate gene expression through chromatin architecture and long-range DNA looping, particularly in MYC proto-oncogene dysregulation. A second research pillar examines the RNA-binding protein tristetraprolin (TTP) and its role in intestinal mRNA degradation and disease pathogenesis (UC, CRC). Recent publications reveal expertise in multi-omics analysis for PSC development in pediatric IBD, metabolic reprogramming in CRC metastasis, and microbiome interactions in diverticulitis. Collaborations with Dr. Walter Koltun's surgical team leverage a biobank of 4,500 intestinal disease patients, integrating genetics, environmental factors, and microbiome studies. Current funded projects include: National Cancer Institute : Wnt/beta-catenin in early-onset CRC (2023-2024) National Cancer Institute : TCF7L1 role in CRC (2020-2022) National Cancer Institute : Nuclear AXIN2 in CRC (2019-2021) National Institute of Diabetes and Digestive and Kidney Diseases : c-Myc transcription in intestinal carcinogenesis (2008-2014) His work contributes to UN Sustainable Development Goals through biomedical research and education.

Magdaléna Harakalováمشاهده پروفایل

استادیار

• Cardiology
• Genetic Cardiomyopathies
• Molecular Biology
• +۴ مورد دیگر

Magdaléna Harakalová is an Assistant Professor at the Department of Cardiology and a member of the Regenerative Medicine Utrecht (RMU) center at Utrecht University Medical Center (UMCU). Her research focuses on molecular mechanisms of inherited cardiomyopathies and personalized medicine strategies. Strategic Programs: Circulatory Health, Regenerative Medicine & Stem Cells Research Group: Inherited Heart Disease (Cardiogenetics) Harakalová investigates how DNA mutations affect cardiomyopathy progression across multi-omics levels (DNA/chromatin/RNA/protein) and cellular/tissue/organism scales using human cardiac tissue and patient-derived iPSC-cardiomyocyte models. Her work aims to redefine cardiomyopathy diagnosis and treatment through next-generation sequencing , bioinformatics , and high-resolution imaging . Recent publications span topics including sex-based proteomic differences , HFrEF subphenotyping , and lipid metabolism targeting , reflecting interdisciplinary approaches to cardiovascular disease mechanisms. Her research aligns with UMCU's Circulatory Health and Regenerative Medicine strategic programs.

Terrence Fureyمشاهده پروفایل

استاد

• Epigenetics
• Gene Regulation
• Inflammatory Bowel Diseases (IBD)
• +۴ مورد دیگر

Dr. Terrence (Terry) Furey is a Professor in the Department of Genetics and Biology at the UNC School of Medicine. His research focuses on gene regulatory processes, particularly epigenetically controlled mechanisms, and their role in complex diseases like inflammatory bowel diseases (IBD). The Furey Lab specializes in computational analysis of genome-wide open chromatin, histone modifications, miRNA, and gene transcription data from high-throughput sequencing experiments. Key research areas: Epigenetics, Chromatin Biology, IBD Pathogenesis, Computational Genomics, Microbiome Interactions Specialized methodologies: Development of statistical and computational tools for genomic data analysis Research highlights include investigating genetic and epigenetic contributors to IBD through collaborations with Dr. Shehzad Sheikh, particularly analyzing chromatin reprogramming, miRNA expression, and microbial composition in both IL-10 knockout models and human intestinal tissues. The lab has identified distinct molecular signatures of Crohn's disease associated with clinical phenotypes. Article trends demonstrate expertise spanning Chromatin accessibility analysis in disease states MicroRNA biomarker discovery in IBD Computational tool development (ROCCO, DeFCoM, GSAASeqSP) Multi-omics integration in complex phenotypes Environmental-genetic interaction studies Translational IBD research Dr. Furey actively collaborates with researchers across the Center for Gastrointestinal Biology and Disease (CGIBD), including Drs. Sartor, Sheikh, and Rusyn. His work bridges clinical/translational research with microbiome studies , focusing on how epigenetic landscape alterations contribute to disease progression.

Catherine McCuskerمشاهده پروفایل

دانشیار

• Developmental Biology
• Molecular Mechanisms of Regeneration
• Epigenetics
• +۴ مورد دیگر

Catherine McCusker is an Associate Professor at the University of Massachusetts Boston's School of Science and Mathematics, Department of Biology, specializing in molecular mechanisms of limb regeneration in axolotls (Ambystoma mexicanum). Her lab focuses on understanding how cells communicate during regeneration, positional information reprogramming, and growth regulation to achieve functional tissue integration. She leads a multidisciplinary team of undergraduate, graduate, and postbaccalaureate researchers. Research interests: Developmental Biology, Molecular Regeneration, Epigenetics, Limb Regeneration Teaching award: 2023 Excellence in Undergraduate Teaching Award Her recent publications explore chromatin modifications, neural control of regeneration, and positional information congruency. Collaborations span regenerative medicine, cancer biology, and conservation science. The lab actively engages in community outreach through virtual lab tours for K-12 students. 2023: Frontiers in Cell and Developmental Biology (Integration failure in limb regeneration) 2022: eLife (Neural growth control), Development (FUCCI marker development) Scientific contributions include high-impact studies on epigenetic regulators (H3K27me3), signaling pathways (FGF/BMP/RA), and axolotl model advancements for regeneration and aging research. Lab members include PhD students, research assistants, and former trainees now in academic or industry roles.

Kellee Siegfriedمشاهده پروفایل

دانشیار

• Developmental Biology
• Genetics
• Germ-cell development
• +۴ مورد دیگر

Associate Professor Kellee Siegfried holds a tenure-track appointment in the Department of Biology at the University of Massachusetts Boston where she leads the Siegfried Laboratory. Trained at UC-Davis (B.S. Genetics) and the University of Wisconsin-Madison (Ph.D. Genetics), she carried out post-doctoral research with Christiane Nüsslein-Volhard before establishing an independent group focused on germ-cell and gonadal development in zebrafish. Education Ph.D. Genetics, University of Wisconsin-Madison B.S. Genetics, University of California, Davis Research Interests The Siegfried Lab exploits the optical and genetic accessibility of zebrafish to ask how germ cells are set aside, how they progress through meiosis, and how the gonad differentiates into testis or ovary. By isolating and molecularly characterizing mutants that disrupt these events, her group has identified conserved genes whose human orthologues underlie infertility and Disorders of Sexual Development (DSD). Current projects integrate forward genetics, CRISPR knock-ins, single-cell RNA-seq and chemical genetics to probe: Genetic control of germ-cell survival and proliferation Mechanisms of meiotic chromosome pairing and recombination Polygenic sex-determination networks Environmental impacts on gonadal differentiation Publication Trends Over the past decade Siegfried’s peer-reviewed output has split into two major streams: (i) mechanistic studies—often led by her lab—on zebrafish germ-cell development, meiosis and sex determination (e.g., dmrt gene circuitry, cohesin function, RNA-binding proteins), and (ii) collaborative cancer-genomics papers that apply the developmental insights to human prostate tumorigenesis, focusing on chromatin modifiers (SETD7, EHMT1/GLP) and lineage plasticity driven by FOXA2/AP-1 rewiring. This duality highlights the translational reach of basic reproductive-biology discoveries. Scientific Awards & Honors No specific awards are listed in the supplied materials; the narrative CV notes invited seminars and steady NIH R01 support but no named prizes or fellowships. Funding & Advising The lab is currently supported by NIH R01 and NSF grants totaling >$1 M per year. Siegfried has mentored numerous Ph.D. students and post-docs; several alumni now run independent groups or biotech positions. Graduate students interested in developmental genetics, genomics or reproductive biology are encouraged to contact her directly. Lab & Team The Siegfried Laboratory (a.k.a. “We go nuts for gonads”) occupies ~1,200 sq ft in the Integrated Sciences Complex on the UMass Boston campus. The team consists of the PI, one post-doc, two graduate students, a research technician and 3-4 undergraduate researchers each semester. Shared zebrafish aquaria (3,000-tank capacity) and core facilities for imaging, genomics and CRISPR reagents are maintained within the same building.